Literature DB >> 21919741

Characterization of inhibitors of glucocorticoid receptor nuclear translocation: a model of cytoplasmic dynein-mediated cargo transport.

Hikmat N Daghestani1, Guangyu Zhu, Paul A Johnston, Sunita N Shinde, Jeffrey L Brodsky, Billy W Day.   

Abstract

Agonist-induced glucocorticoid receptor [GR] transport from the cytoplasm to the nucleus was used as a model to identify dynein-mediated cargo transport inhibitors. Cell-based screening of the library of pharmacologically active compound (LOPAC)-1280 collection identified several small molecules that stalled the agonist-induced transport of GR-green fluorescent protein (GFP) in a concentration-dependent manner. Fluorescent images of microtubule organization, nuclear DNA staining, expression of GR-GFP, and its subcellular distribution were inspected and quantified by image analysis to evaluate the impact of compounds on cell morphology, toxicity, and GR transport. Given the complexity of the multi-protein complex involved in dynein-mediated cargo transport and the variety of potential mechanisms for interruption of that process, we therefore developed and validated a panel of biochemical assays to investigate some of the more likely intracellular target(s) of the GR transport inhibitors. Although the apomorphine enantiomers exhibited the most potency toward the ATPase activities of cytoplasmic dynein, myosin, and the heat-shock proteins (HSPs), their apparent lack of specificity made them unattractive for further study in our quest. Other molecules appeared to be nonspecific inhibitors that targeted reactive cysteines of proteins. Ideally, specific retrograde transport inhibitors would either target dynein itself or one of the other important proteins associated with the transport process. Although the hits from the cell-based screen of the LOPAC-1280 collection did not exhibit this desired profile, this screening platform provided a promising phenotypic system for the discovery of dynein/HSP modulators.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21919741      PMCID: PMC3277738          DOI: 10.1089/adt.2010.0367

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  53 in total

Review 1.  Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement.

Authors:  William B Pratt; Mario D Galigniana; Jennifer M Harrell; Donald B DeFranco
Journal:  Cell Signal       Date:  2004-08       Impact factor: 4.315

2.  Cytoplasmic dynein is required for poleward chromosome movement during mitosis in Drosophila embryos.

Authors:  D J Sharp; G C Rogers; J M Scholey
Journal:  Nat Cell Biol       Date:  2000-12       Impact factor: 28.824

3.  Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate.

Authors:  P D Reynolds; S J Pittler; J G Scammell
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

4.  Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit.

Authors:  K Helen Bremner; Julian Scherer; Julie Yi; Michael Vershinin; Steven P Gross; Richard B Vallee
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

5.  Heat shock protein 90 in neurodegenerative diseases.

Authors:  Wenjie Luo; Weilin Sun; Tony Taldone; Anna Rodina; Gabriela Chiosis
Journal:  Mol Neurodegener       Date:  2010-06-03       Impact factor: 14.195

6.  Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics.

Authors:  Paraskevi Giannakakou; Michel Nakano; Kyriacos C Nicolaou; Aurora O'Brate; Jian Yu; Mikhail V Blagosklonny; Urs F Greber; Tito Fojo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

7.  Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus.

Authors:  Mario D Galigniana; Jennifer M Harrell; Heather M O'Hagen; Mats Ljungman; William B Pratt
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

8.  Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.

Authors:  E ter Haar; R J Kowalski; E Hamel; C M Lin; R E Longley; S P Gunasekera; H S Rosenkranz; B W Day
Journal:  Biochemistry       Date:  1996-01-09       Impact factor: 3.162

Review 9.  AAA proteins. Lords of the ring.

Authors:  R D Vale
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

10.  Visualization of the intracellular behavior of HIV in living cells.

Authors:  David McDonald; Marie A Vodicka; Ginger Lucero; Tatyana M Svitkina; Gary G Borisy; Michael Emerman; Thomas J Hope
Journal:  J Cell Biol       Date:  2002-11-04       Impact factor: 10.539

View more
  7 in total

1.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

2.  Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen.

Authors:  Ashley T Fancher; Yun Hua; Daniel P Camarco; David A Close; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2016-09-08       Impact factor: 1.738

3.  High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.

Authors:  Yun Hua; Tong Ying Shun; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2014-09       Impact factor: 1.738

4.  Development and validation of a high-content screening assay to identify inhibitors of cytoplasmic dynein-mediated transport of glucocorticoid receptor to the nucleus.

Authors:  Paul A Johnston; Sunita N Shinde; Yun Hua; Tong Ying Shun; John S Lazo; Billy W Day
Journal:  Assay Drug Dev Technol       Date:  2012-07-25       Impact factor: 1.738

5.  Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor.

Authors:  Ashley T Fancher; Yun Hua; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2019-09-06       Impact factor: 1.738

6.  High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer.

Authors:  Ashley T Fancher; Yun Hua; Daniel P Camarco; David A Close; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2018-08-15       Impact factor: 1.738

7.  Association of DYNC1H1 gene SNP/CNV with disease susceptibility, GCs efficacy, HRQOL, anxiety, and depression in Chinese SLE patients.

Authors:  Shunwei Huang; Tingyu Zhang; Yuhua Wang; Linlin Wang; Ziye Yan; Ying Teng; Zhen Li; Qiuyue Lou; Shuang Liu; Jing Cai; Yangfan Chen; Mu Li; Hailiang Huang; Zhouzhou Xu; Yanfeng Zou
Journal:  J Clin Lab Anal       Date:  2021-07-17       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.